Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bone Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bmt.2008.271PMID 18762764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunity to fungal infections

  2011cited by this paper
• Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors

  2007cited by this paper
• Generation of Trispecific Cytotoxic T Cells Recognizing Cytomegalovirus, Adenovirus, and Epstein-Barr Virus: An Approach for Adoptive Immunotherapy of Multiple Pathogens

  2007cited by this paper
• Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors

  2007cited by this paper
• Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant.

  2007cited by this paper
• Immunotherapy for fungal infections.

  2006cited by this paper
• Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus.

  2006cited by this paper
• Ex vivo Expansion of Highly Purified NK Cells for Immunotherapy after Haploidentical Stem Cell Transplantation in Children

  2005cited by this paper
• Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

  2005cited by this paper
• Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes.

  2004cited by this paper
• Aspergillus fumigatus antigens activate innate immune cells via toll‐like receptors 2 and 4

  2004cited by this paper
• Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma

  2004cited by this paper
• Immunity to fungal infections

  2004cited by this paper
• Extrathymic T-cell differentiation in vitro

  2004cited by this paper
• Mature Dendritic Cells Derived from Human Monocytes Within 48 Hours: A Novel Strategy for Dendritic Cell Differentiation from Blood Precursors1

  2003cited by this paper
• Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

  2002cited by this paper
• Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 22, 2013. For personal use only.

  2002cited by this paper
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

  2002cited by this paper
• Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.

  2002cited by this paper
• Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

  2001cited by this paper
• T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis1

  2000cited by this paper
• Aspergillus fumigatus and Aspergillosis

  1999cited by this paper
• Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.

  1997cited by this paper
• Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

  1996cited by this paper

• A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus

  2024cites this paper
• Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure

  2023cites this paper
• Exploiting antifungal immunity in the clinical context.

  2023cites this paper
• Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond

  2023cites this paper
• Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art

  2021cites this paper
• Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

  2021cites this paper
• From bench to bedside - translational approaches in anti-fungal immunology.

  2020cites this paper
• Fungal Infections in Immunocompromised Hosts

  2019cites this paper
• The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation

  2019cites this paper
• Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host

  2019cites this paper
• Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus

  2019cites this paper
• Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host

  2019cites this paper
• Specific Adoptive T-Cell Therapy for Viral and Fungal Infections

  2018cites this paper
• Immunomodulation as Therapy for Fungal Infection: Are We Closer?

  2018cites this paper
• Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives

  2018cites this paper
• Invasive Pulmonary Aspergillosis (IPA) Post Hematopoietic Stem Cell Transplant (HSCT): Is Immunological Dysfunction Play a Role?

  2018cites this paper
• The Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus

  2017cites this paper
• Prospects for adoptive T-cell therapy for invasive fungal disease

  2017cites this paper
• Immunotherapy of Invasive Fungal Disease

  2017cites this paper
• Intra‐ and inter‐individual variability of Aspergillus fumigatus reactive T‐cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment

  2017cites this paper
• Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk.

  2016cites this paper
• Immunotherapy for opportunistic infections: Current status and future perspectives

  2016cites this paper
• Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapies

  2016cites this paper
• Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges.

  2016cites this paper
• Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells.

  2016cites this paper
• Adoptive T-cell therapy for fungal infections in haematology patients

  2015cites this paper
• Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.

  2015cites this paper
• Moving towards pathogen‐specific T cells post‐stem cell transplant as standard of care

  2015cites this paper
• Antifungal T cells--progress in manufacture and prospects for the clinic.

  2015cites this paper
• Identification of Immunogenic Antigens from Aspergillus fumigatus by Direct Multiparameter Characterization of Specific Conventional and Regulatory CD4+ T Cells

  2014cites this paper
• Conventional and Regulatory CD 4 Multiparameter Characterization of Specific by Direct Aspergillus fumigatus Identification of Immunogenic Antigens from Scheffold

  2014cites this paper
• Immunosuppressive Compounds Exhibit Particular Effects on Functional Properties of Human Anti-Aspergillus TH1 Cells

  2014cites this paper
• A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients

  2014cites this paper
• Identification of Immunogenic Antigens from Aspergillus fumigatus by Direct Multiparameter Characterization of Specific Conventional and Regulatory CD 4 + T Cells

  2014cites this paper
• Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells

  2014cites this paper
• Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

  2013cites this paper
• Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients

  2013cites this paper
• Highlights of the Third International Conference on Immunotherapy in Pediatric Oncology

  2013cites this paper
• Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.

  2013cites this paper
• Monitoring of Pathogen-Specific T-Cell Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

  2013cites this paper
• In vitro induction and expansion of CD8 positive T cells

  2013cites this paper
• Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.

  2013cites this paper
• Regional cytokine responses to pulmonary aspergillosis in immunocompetent rats.

  2013cites this paper
• Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.

  2012cites this paper
• In-vitro Generation of potent T-lymphoid Progenitors in a feeder-cell-free DL-4 system

  2012cites this paper
• Enhancing immune responses to limit chronic immune activation during SIV.

  2012cites this paper
• NADPH oxidase regulates efficacy of vaccination in aspergillosis.

  2012cites this paper
• Immunotherapy against invasive mold infections.

  2012cites this paper
• Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine

  2012cites this paper
• Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus.

  2012cites this paper
• Apport des méthodes d’isolement immunomagnétique de lymphocytes T cytotoxiques dans la restauration rapide d’une immunité antivirale après allogreffe de cellules souches hématopoïétiques

  2012cites this paper
• Expansion of melanoma-specific T cells from lymph nodes of patients in stage III: implications for adoptive immunotherapy in treating cancer.

  2012cites this paper
• Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.

  2011cites this paper
• CD4+ T Cells Mediate the Protective Effect of the Recombinant Asp f3-Based Anti-Aspergillosis Vaccine

  2011cites this paper
• Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation.

  2011cites this paper
• Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

  2011cites this paper
• Immunotherapy Against Invasive Fungal Diseases in Stem Cell Transplant Recipients

  2011cites this paper
• Highlights of the Second International Conference on “Immunotherapy in Pediatric Oncology”

  2011cites this paper
• Overview of Invasive Fungal Disease in Oncology Patients

  2011cites this paper
• Chapter 1

  2011cites this paper
• Adoptive antifungal T cell immunotherapy--into the clinic?

  2011cites this paper
• Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

  2010influential citation
• Reconstitution immunitaire et immunothérapie adoptive anti-virales après allogreffe de cellules souches hématopoiétiques

  2010cites this paper
• Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias.

  2010cites this paper
• Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.

  2010cites this paper
• Healthy Human T-Cell Responses to Aspergillus fumigatus Antigens

  2010cites this paper
• Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

  2010influential citation
• Advances in adoptive immunotherapy to accelerate T-cellular immune reconstitution after HLA-incompatible hematopoietic stem cell transplantation.

  2010cites this paper
• Challenges and Prospects of Adoptive Immunotherapy in Prevention and Treatment of Opportunistic Mycoses in Hematologic Transplant Recipients

  2010cites this paper
• Infektionen und Immuntherapie

  2010cites this paper
• Diagnosis of aspergillosis: Role of proteomics

  2009cites this paper
• New cellular therapies: Is there a role for transfusion services?

  2009cites this paper
• Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host.

  2009cites this paper